Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 6, 2017, Pages 1180-1193

  Dou, Huijuan ^a   Feher, Attila ^a   Davila, Alec C ^a   Romero, Maritza J ^a,c   Patel, Vijay S ^b   Kamath, Vinayak M ^b   Gooz, Monika Beck ^d   Rudic, R Daniel ^c   Lucas, Rudolf ^a,c   Fulton, David J ^a,c   Weintraub, Neal L ^a,b   Bagi, Zsolt ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Surgery ^*  (Australia)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

adipose tissue; aging; caveolin 1; endothelium; humans; obesity

Indexed keywords

CARBON TETRACHLORIDE; CAVEOLIN 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM17 PROTEIN, HUMAN; ADAM17 PROTEIN, MOUSE; CAV1 PROTEIN, HUMAN; CAV1 PROTEIN, MOUSE;

ADIPOSE TISSUE; AGED; AGING; ARTERIOLE; ARTICLE; BIOASSAY; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY MICROVASCULAR DYSFUNCTION; FEMALE; GENE DELETION; HEART ATRIUM APPENDAGE; HUMAN; LIPID DIET; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MOUSE; NONHUMAN; OBESITY; OPEN HEART SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; ADULT; AGE; ANIMAL; C57BL MOUSE; CELL CULTURE; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DEFICIENCY; DISEASE MODEL; ENDOTHELIUM CELL; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSPLANTATION; VASODILATATION; VERY ELDERLY;

ADAM17 PROTEIN; ADIPOSE TISSUE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ARTERIOLES; CAVEOLIN 1; CELLS, CULTURED; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; OBESITY; RISK FACTORS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 85019769247     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.117.309430     Document Type: Article

References (56)

1. Nemes A, Forster T, Csanády M, Diminished coronary flow velocity reserve and aortic distensibility in elderly patients with chest pain and negative coronary angiograms. Aging Clin Exp Res 2008 20 297 301
2. Camici PG, Crea F, Coronary microvascular dysfunction. N Engl J Med 2007 356 830 840. doi: 10.1056/NEJMra061889.
3. Udelson JE, Heart failure with preserved ejection fraction. Circulation 2011 124 e540 e543. doi: 10.1161/CIRCULATIONAHA.111.071696.
4. Silverman MG, Patel B, Blankstein R, Lima JA, Blumenthal RS, Nasir K, Blaha MJ, Impact of race, ethnicity, and multimodality biomarkers on the incidence of new-onset heart failure with preserved ejection fraction (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2016 117 1474 1481. doi: 10.1016/j.amjcard.2016.02.017.
5. Paulus WJ, Tschöpe C, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013 62 263 271. doi: 10.1016/j.jacc.2013.02.092.
6. Franssen C, Chen S, Unger A, Korkmaz HI, De Keulenaer GW, Tschöpe C, Leite-Moreira AF, Musters R, Niessen HW, Linke WA, Paulus WJ, Hamdani N, Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 2016 4 312 324. doi: 10.1016/j.jchf.2015.10.007.
7. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB, Framingham Heart Study Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003 107 1486 1491
8. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad.
9. Rutkowski JM, Stern JH, Scherer PE, The cell biology of fat expansion. J Cell Biol 2015 208 501 512. doi: 10.1083/jcb.201409063.
10. Owen MK, Noblet JN, Sassoon DJ, Conteh AM, Goodwill AG, Tune JD, Perivascular adipose tissue and coronary vascular disease. Arterioscler Thromb Vasc Biol 2014 34 1643 1649. doi: 10.1161/ATVBAHA.114.303033.
11. Payne GA, Borbouse L, Kumar S, Neeb Z, Alloosh M, Sturek M, Tune JD, Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-beta pathway. Arterioscler Thromb Vasc Biol 2010 30 1711 1717. doi: 10.1161/ATVBAHA.110.210070.
12. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y, Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003 108 2460 2466. doi: 10.1161/01.CIR.0000099542.57313.C5.
13. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhøj P, Pedersen BK, A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999 54 M357 M364
14. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, D'Onofrio F, Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 1998 275 2 pt 1 E294 E299
15. Hotamisligil GS, Spiegelman BM, Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994 43 1271 1278
16. Hotamisligil GS, Shargill NS, Spiegelman BM, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993 259 87 91
17. Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, Zhang C, Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 2007 115 245 254. doi: 10.1161/CIRCULATIONAHA.106.650671.
18. Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C, Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006 99 69 77. doi: 10.1161/01.RES.0000229685.37402.80.
19. Cassuto J, Dou H, Czikora I, Szabo A, Patel VS, Kamath V, Belin de Chantemele E, Feher A, Romero MJ, Bagi Z, Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients. Diabetes 2014 63 1381 1393. doi: 10.2337/db13-0577.
20. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E, Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000 101 2149 2153
21. Gormez S, Demirkan A, Atalar F, Caynak B, Erdim R, Sozer V, Gunay D, Akpinar B, Ozbek U, Buyukdevrim AS, Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease. Intern Med 2011 50 805 810
22. Konishi M, Sugiyama S, Sugamura K, Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 2010 209 573 578. doi: 10.1016/j.atherosclerosis.2009.10.008.
23. Huang A, Yang YM, Feher A, Bagi Z, Kaley G, Sun D, Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2012 302 R674 R681. doi: 10.1152/ajpregu.00699.2011.
24. Bailey-Downs LC, Tucsek Z, Toth P, Sosnowska D, Gautam T, Sonntag WE, Csiszar A, Ungvari Z, Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci 2013 68 780 792. doi: 10.1093/gerona/gls238.
25. Gooz M, ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol 2010 45 146 169. doi: 10.3109/10409231003628015.
26. Voros G, Maquoi E, Collen D, Lijnen HR, Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochim Biophys Acta 2003 1625 36 42
27. Takaguri A, Shirai H, Kimura K, Hinoki A, Eguchi K, Carlile-Klusacek M, Yang B, Rizzo V, Eguchi S, Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II. J Mol Cell Cardiol 2011 50 545 551. doi: 10.1016/j.yjmcc.2010.12.009.
28. D'Alessio A, Esposito B, Giampietri C, Ziparo E, Pober JS, Filippini A, Plasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells. J Cell Mol Med 2012 16 627 636. doi: 10.1111/j.1582-4934.2011.01353.x.
29. Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A, Mouillet-Richard S, Haik S, Bailly Y, Peyrin JM, Launay JM, Kellermann O, Schneider B, PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med 2013 19 1124 1131. doi: 10.1038/nm.3302.
30. Czikora I, Feher A, Lucas R, Fulton DJ, Bagi Z, Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure. Am J Physiol Heart Circ Physiol 2015 308 H376 H385. doi: 10.1152/ajpheart.00649.2014.
31. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M, Reitman ML, Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000 105 271 278. doi: 10.1172/JCI7901.
32. Jebelovszki E, Kiraly C, Erdei N, Feher A, Pasztor ET, Rutkai I, Forster T, Edes I, Koller A, Bagi Z, High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am J Physiol Heart Circ Physiol 2008 294 H2558 H2564. doi: 10.1152/ajpheart.01198.2007.
33. Feher A, Rutkai I, Beleznai T, Ungvari Z, Csiszar A, Edes I, Bagi Z, Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity. Cardiovasc Res 2010 87 732 739. doi: 10.1093/cvr/cvq088.
34. Fulop T, Jebelovszki E, Erdei N, Szerafin T, Forster T, Edes I, Koller A, Bagi Z, Adaptation of vasomotor function of human coronary arterioles to the simultaneous presence of obesity and hypertension. Arterioscler Thromb Vasc Biol 2007 27 2348 2354. doi: 10.1161/ATVBAHA.107.147991.
35. Cassuto J, Feher A, Lan L, Patel VS, Kamath V, Anthony DC, Bagi Z, Obesity and statins are both independent predictors of enhanced coronary arteriolar dilation in patients undergoing heart surgery. J Cardiothorac Surg 2013 8 117. doi: 10.1186/1749-8090-8-117.
36. Bagi Z, Mechanisms of coronary microvascular adaptation to obesity. Am J Physiol Regul Integr Comp Physiol 2009 297 R556 R567. doi: 10.1152/ajpregu.90817.2008.
37. Bagi Z, Feher A, Cassuto J, Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol 2012 165 544 560. doi: 10.1111/j.1476-5381.2011.01606.x.
38. Oltman CL, Richou LL, Davidson EP, Coppey LJ, Lund DD, Yorek MA, Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2006 291 H1780 H1787. doi: 10.1152/ajpheart.01297.2005.
39. Payne GA, Kohr MC, Tune JD, Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol 2012 165 659 669. doi: 10.1111/j.1476-5381.2011.01370.x.
40. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr., Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003 112 1796 1808. doi: 10.1172/JCI19246.
41. Imaizumi T, Itaya H, Fujita K, Kudoh D, Kudoh S, Mori K, Fujimoto K, Matsumiya T, Yoshida H, Satoh K, Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha. Arterioscler Thromb Vasc Biol 2000 20 410 415
42. Chan EL, Haudek SB, Giroir BP, Murphy JT, Human coronary endothelial cell activation by endotoxin is characterized by NF-kappa B activation and TNF-alpha synthesis. Shock 2001 16 349 354
43. Freyer D, Manz R, Ziegenhorn A, Weih M, Angstwurm K, Döcke WD, Meisel A, Schumann RR, Schönfelder G, Dirnagl U, Weber JR, Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol 1999 163 4308 4314
44. Winkler G, Kiss S, Keszthelyi L, Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 2003 149 129 135
45. Takayanagi T, Crawford KJ, Kobayashi T, Obama T, Tsuji T, Elliott KJ, Hashimoto T, Rizzo V, Eguchi S, Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase. Clin Sci (Lond) 2014 126 785 794. doi: 10.1042/CS20130660.
46. Cohen AW, Hnasko R, Schubert W, Lisanti MP, Role of caveolae and caveolins in health and disease. Physiol Rev 2004 84 1341 1379. doi: 10.1152/physrev.00046.2003.
47. García-Cardeña G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC, Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 1997 272 25437 25440
48. Michel JB, Feron O, Sacks D, Michel T, Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem 1997 272 15583 15586
49. Ju H, Zou R, Venema VJ, Venema RC, Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997 272 18522 18525
50. Guo Q, Shen N, Yuan K, Li J, Wu H, Zeng Y, Fox J III, Bansal AK, Singh BB, Gao H, Wu M, Caveolin-1 plays a critical role in host immunity against Klebsiella pneumoniae by regulating STAT5 and Akt activity. Eur J Immunol 2012 42 1500 1511. doi: 10.1002/eji.201142051.
51. Yuan K, Huang C, Fox J, Gaid M, Weaver A, Li G, Singh BB, Gao H, Wu M, Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB). J Biol Chem 2011 286 21814 21825. doi: 10.1074/jbc.M111.237628.
52. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 2000 6 1362 1367. doi: 10.1038/82176.
53. Zou H, Stoppani E, Volonte D, Galbiati F, Caveolin-1, cellular senescence and age-related diseases. Mech Ageing Dev 2011 132 533 542. doi: 10.1016/j.mad.2011.11.001.
54. Lucitti JL, Mackey JK, Morrison JC, Haigh JJ, Adams RH, Faber JE, Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17. Circ Res 2012 111 1539 1550. doi: 10.1161/CIRCRESAHA.112.279109.
55. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, Scherer PE, Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 2014 20 103 118. doi: 10.1016/j.cmet.2014.05.005.
56. Rutkowski JM, Davis KE, Scherer PE, Mechanisms of obesity and related pathologies: the macro-and microcirculation of adipose tissue. FEBS J 2009 276 5738 5746. doi: 10.1111/j.1742-4658.2009.07303.x.